| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94 |
| filingDate |
2006-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92f24cd021c5ddcde7b6082bccb380c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76abbced43495fad3b1429b64f6de4ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c3d371d4e7677a273ffe80ea181388a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff0d0397e12abd1a19286641ca96bf27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40df67acd6a8958d4fa8f6c98546a504 |
| publicationDate |
2008-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2008306096-A1 |
| titleOfInvention |
Quinazoline Derivatives, Process for Their Preparation and Their Use as Anti-Cancer Agents |
| abstract |
The invention relates to chemical compounds of the formula (I) or pharmaceutically acceptable salts thereof, which possess B Raf inhibitory activity and are accordingly useful for their anti cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm blooded animal such as man. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011092479-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8394795-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8338452-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011003859-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011003809-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011110889-A1 |
| priorityDate |
2005-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |